But its certainly promising. New research builds on evidence suggesting that semaglutide, the active ingredient in GLP-1 drugs like Ozempic and Wegovy, could help treat alcohol use disorder
As of January 2026, 13 states (Delaware, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Rhode Island, Tennessee, Utah, Virginia, and Wisconsin) cover GLP-1 receptor agonists (such as Wegovy) for weight loss
A history of breast cancer is not a contraindication to Mounjaro, but the decision requires individualised assessment and consultation with your oncology team
Perhaps my running habit took root because I had the right rewards: I like to be outside, I wanted the photo, I savored the coffee more knowing I had done something
Planning on losing a few more